These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22451576)

  • 21. Concordance of BI-RADS Assessments and Management Recommendations for Breast MRI in Community Practice.
    Lee AY; Ichikawa L; Lee JM; Lee CI; DeMartini WB; Joe BN; Wernli KJ; Sprague BL; Herschorn SD; Lehman CD
    AJR Am J Roentgenol; 2016 Jan; 206(1):211-6. PubMed ID: 26700354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Background Parenchymal Enhancement on Diagnostic Performance in Screening Breast MRI.
    Sippo DA; Rutledge GM; Mercaldo SF; Burk KS; Edmonds CE; Dang PA; Lehman CD
    Acad Radiol; 2020 May; 27(5):663-671. PubMed ID: 31327575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Should breast MRI be performed with adjustment for the phase in patients' menstrual cycle? Correlation between mammographic density, age, and background enhancement on breast MRI without adjusting for the phase in patients' menstrual cycle.
    Uematsu T; Kasami M; Watanabe J
    Eur J Radiol; 2012 Jul; 81(7):1539-42. PubMed ID: 21592704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. False-positive findings at contrast-enhanced breast MRI: a BI-RADS descriptor study.
    Baltzer PA; Benndorf M; Dietzel M; Gajda M; Runnebaum IB; Kaiser WA
    AJR Am J Roentgenol; 2010 Jun; 194(6):1658-63. PubMed ID: 20489110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequency and Cancer Yield of BI-RADS Category 3 Lesions Detected at High-Risk Screening Breast MRI.
    Edmonds CE; Lamb LR; Mercaldo SF; Sippo DA; Burk KS; Lehman CD
    AJR Am J Roentgenol; 2020 Feb; 214(2):240-248. PubMed ID: 31799867
    [No Abstract]   [Full Text] [Related]  

  • 26. Impact of menopausal status on background parenchymal enhancement and fibroglandular tissue on breast MRI.
    King V; Gu Y; Kaplan JB; Brooks JD; Pike MC; Morris EA
    Eur Radiol; 2012 Dec; 22(12):2641-7. PubMed ID: 22752463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Value of breast MRI for patients with a biopsy showing atypical ductal hyperplasia (ADH).
    Tsuchiya K; Mori N; Schacht DV; Sheth D; Karczmar GS; Newstead GM; Abe H
    J Magn Reson Imaging; 2017 Dec; 46(6):1738-1747. PubMed ID: 28295791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effective factors to raise diagnostic performance of breast MRI for diagnosing pathologic complete response in breast cancer patients after neoadjuvant chemotherapy.
    Choi BB; Kim SH
    Acta Radiol; 2015 Jul; 56(7):790-7. PubMed ID: 24951616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of background parenchymal echogenicity on breast ultrasound: Correlation with mammographic breast density and background parenchymal enhancement on magnetic resonance imaging.
    Ko KH; Jung HK; Kim I
    Medicine (Baltimore); 2017 Aug; 96(33):e7850. PubMed ID: 28816987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patterns of nonmasslike enhancement at screening breast MR imaging of high-risk premenopausal women.
    Giess CS; Raza S; Birdwell RL
    Radiographics; 2013; 33(5):1343-60. PubMed ID: 24025928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of background parenchymal enhancement and fibroglandular density at breast magnetic resonance imaging between BRCA gene mutation carriers and non-carriers.
    Grubstein A; Rapson Y; Benzaquen O; Rozenblatt S; Gadiel I; Atar E; Yerushalmi R; Cohen MJ
    Clin Imaging; 2018; 51():347-351. PubMed ID: 29982132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of background parenchymal enhancement on breast cancer detection with magnetic resonance imaging.
    Telegrafo M; Rella L; Stabile Ianora AA; Angelelli G; Moschetta M
    Diagn Interv Imaging; 2016 Mar; 97(3):315-20. PubMed ID: 26970658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative effectiveness of breast MRI and mammography in screening young women with elevated risk of developing breast cancer: a retrospective cohort study.
    Narayan AK; Visvanathan K; Harvey SC
    Breast Cancer Res Treat; 2016 Aug; 158(3):583-9. PubMed ID: 27444927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An Abbreviated Protocol for High-risk Screening Breast Magnetic Resonance Imaging: Impact on Performance Metrics and BI-RADS Assessment.
    Panigrahi B; Mullen L; Falomo E; Panigrahi B; Harvey S
    Acad Radiol; 2017 Sep; 24(9):1132-1138. PubMed ID: 28506511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Background parenchymal uptake during molecular breast imaging and associated clinical factors.
    Hruska CB; Rhodes DJ; Conners AL; Jones KN; Carter RE; Lingineni RK; Vachon CM
    AJR Am J Roentgenol; 2015 Mar; 204(3):W363-70. PubMed ID: 25714323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast imaging reporting and data system (BI-RADS) lexicon for breast MRI: interobserver variability in the description and assignment of BI-RADS category.
    El Khoury M; Lalonde L; David J; Labelle M; Mesurolle B; Trop I
    Eur J Radiol; 2015 Jan; 84(1):71-76. PubMed ID: 25454100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Positive predictive value of BI-RADS MR imaging.
    Mahoney MC; Gatsonis C; Hanna L; DeMartini WB; Lehman C
    Radiology; 2012 Jul; 264(1):51-8. PubMed ID: 22589320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of breast cancer with MRI background parenchymal enhancement: the IMAGINE case-control study.
    Watt GP; Sung J; Morris EA; Buys SS; Bradbury AR; Brooks JD; Conant EF; Weinstein SP; Kontos D; Woods M; Colonna SV; Liang X; Stein MA; Pike MC; Bernstein JL
    Breast Cancer Res; 2020 Dec; 22(1):138. PubMed ID: 33287857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High cancer yield and positive predictive value: outcomes at a center routinely using preoperative breast MRI for staging.
    Gutierrez RL; DeMartini WB; Silbergeld JJ; Eby PR; Peacock S; Javid SH; Lehman CD
    AJR Am J Roentgenol; 2011 Jan; 196(1):W93-9. PubMed ID: 21178040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High resolution MRI of the breast at 3 T: which BI-RADS® descriptors are most strongly associated with the diagnosis of breast cancer?
    Pinker-Domenig K; Bogner W; Gruber S; Bickel H; Duffy S; Schernthaner M; Dubsky P; Pluschnig U; Rudas M; Trattnig S; Helbich TH
    Eur Radiol; 2012 Feb; 22(2):322-30. PubMed ID: 21913060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.